CCBE1 and neoplasm: Nuclear SMAD2 expression was found in tumor cells of 45% of CRC samples (Figure 6F) and in tumor stroma of 70% of cases (Figure 6G), in which CCBE1 expression was significantly lower than in the samples with cytoplasmic SMAD2 staining.